Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Pollen Allergenic Extract [EPC]
Artemisia Vulgaris Pollen is a non-standardized allergenic extract used for the diagnosis and treatment of mugwort-induced allergic rhinitis and asthma. It belongs to the class of non-standardized pollen allergenic extracts.
Name
Artemisia Vulgaris Pollen
Raw Name
ARTEMISIA VULGARIS POLLEN
Category
Non-Standardized Pollen Allergenic Extract [EPC]
Drug Count
25
Variant Count
27
Last Verified
February 17, 2026
About Artemisia Vulgaris Pollen
Artemisia Vulgaris Pollen is a non-standardized allergenic extract used for the diagnosis and treatment of mugwort-induced allergic rhinitis and asthma. It belongs to the class of non-standardized pollen allergenic extracts.
Detailed information about Artemisia Vulgaris Pollen
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Artemisia Vulgaris Pollen.
Artemisia Vulgaris Pollen, commonly known as Mugwort pollen, is a biological substance used in clinical immunology for both diagnostic and therapeutic purposes. It belongs to a broad pharmacological class known as Non-Standardized Pollen Allergenic Extracts [EPC]. These extracts are derived from the pollen of the Artemisia vulgaris plant, a perennial weed that is a significant cause of hay fever (allergic rhinitis) and allergic asthma across Europe, North America, and parts of Asia during the late summer and autumn months.
In the clinical setting, Artemisia Vulgaris Pollen is utilized in two primary ways: as a diagnostic tool in skin prick testing (to identify sensitization to the allergen) and as the active ingredient in allergen immunotherapy (AIT), often referred to as "allergy shots." The FDA has historically regulated these extracts under biological product standards, acknowledging their role in managing Type I hypersensitivity reactions. Unlike standardized extracts, which have a defined potency based on bioequivalent units, non-standardized extracts like Artemisia Vulgaris are typically measured in Protein Nitrogen Units (PNU) or Weight/Volume (w/v) ratios.
The mechanism of Artemisia Vulgaris Pollen depends on its application. When used for diagnosis, the extract is introduced into the skin. In sensitized individuals, the major allergens within the pollen (such as Art v 1 and Art v 3) bind to specific Immunoglobulin E (IgE) antibodies attached to the surface of mast cells. This binding triggers the degranulation (release) of inflammatory mediators like histamine and leukotrienes, resulting in a localized "wheal and flare" reaction within 15 to 20 minutes.
When used for immunotherapy, the mechanism involves a complex modulation of the immune system over a period of 3 to 5 years. The goal is to induce immunological tolerance. This is achieved through several molecular pathways:
Traditional pharmacokinetic parameters (absorption, distribution, metabolism, and excretion) do not apply to allergenic extracts in the same way they do to synthetic small-molecule drugs.
Artemisia Vulgaris Pollen extract is indicated for:
> Important: Only your healthcare provider can determine if Artemisia Vulgaris Pollen is right for your specific condition. Immunotherapy must always be administered under the supervision of a physician prepared to treat anaphylaxis.
Dosage for Artemisia Vulgaris Pollen is highly individualized and must be determined by an allergist based on the patient's sensitivity levels.
Artemisia Vulgaris Pollen is generally considered safe for children over the age of 5. Dosing follows the same build-up and maintenance principles as adults, though smaller volume increments may be used in highly sensitive children. Use in children under 5 is rare and requires careful risk-benefit analysis due to the difficulty of children communicating early symptoms of a systemic reaction.
No specific dose adjustments are required for renal impairment, as the extract is not primarily cleared by the kidneys in its active form. However, patients with severe renal disease may be at higher risk if they require epinephrine for a reaction.
No dosage adjustments are necessary for patients with liver disease.
Caution is advised in elderly patients (over 65) due to the higher prevalence of underlying cardiovascular disease, which may make them less able to tolerate a systemic reaction or the treatment required (epinephrine).
If a dose is missed during the build-up phase, the next dose may need to be reduced or the previous dose repeated, depending on the time elapsed. If a maintenance dose is missed by more than 2 weeks, the physician will typically reduce the dose for the next injection to ensure safety. Never attempt to "double up" on doses at home.
An overdose occurs if too much allergen is injected or if the injection is accidentally given intravenously.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or frequency without medical guidance. The success of immunotherapy depends on strict adherence to the schedule.
Most patients undergoing treatment with Artemisia Vulgaris Pollen will experience local reactions.
> Warning: Stop receiving Artemisia Vulgaris Pollen and call your doctor immediately or seek emergency care if you experience any of the following:
There are no known long-term toxicities associated with Artemisia Vulgaris Pollen extracts. The primary long-term effect is the intended modification of the immune system. However, repeated injections over several years can occasionally cause localized "lumps" (subcutaneous nodules) or scarring at the injection site if the location is not rotated properly.
While non-standardized extracts may not always carry a formal "Black Box" in the same way as newer sublingual tablets, the FDA-approved labeling for all allergenic extracts includes a Severe Warning regarding Anaphylaxis:
Report any unusual symptoms, even if they seem mild, to your healthcare provider before your next scheduled injection.
Artemisia Vulgaris Pollen is a potent biological agent. Its use is restricted to individuals with a documented IgE-mediated allergy to Mugwort pollen. It is not effective for non-allergic (vasomotor) rhinitis. Safety depends entirely on the accuracy of the dose and the clinical environment in which it is administered.
No FDA black box warnings for Artemisia Vulgaris Pollen are currently mandated in the same format as pharmaceutical drugs; however, the class-wide warning for allergenic extracts is considered equivalent in severity. It emphasizes that anaphylaxis can occur even in patients who have previously tolerated the injections without issue.
Generally, Artemisia Vulgaris Pollen does not cause sedation. However, if a patient experiences a systemic reaction or receives antihistamines/epinephrine for a reaction, they should not drive or operate machinery until they are fully recovered and cleared by a physician.
Alcohol should be avoided for several hours before and after an injection. Alcohol can cause vasodilation (widening of blood vessels), which may increase the rate of allergen absorption and potentially trigger or worsen a systemic reaction.
Immunotherapy is typically discontinued if:
> Important: Discuss all your medical conditions, especially respiratory or heart problems, with your healthcare provider before starting Artemisia Vulgaris Pollen.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for blood pressure, heart rhythm, or depression.
Patients allergic to Artemisia Vulgaris Pollen often show cross-reactivity with other members of the Asteraceae (Compositae) family, including:
> Important: Your healthcare provider will evaluate your complete medical history, including your current lung function and heart health, before prescribing Artemisia Vulgaris Pollen.
Pregnancy Category C. There are no adequate and well-controlled studies of Artemisia Vulgaris Pollen in pregnant women.
It is not known whether allergenic extract components are excreted in human milk. Because these are large proteins that are likely digested in the infant's gut, the risk to a nursing infant is considered very low. Breastfeeding is not a contraindication to receiving Artemisia Vulgaris Pollen injections.
Patients over 65 require a thorough cardiovascular evaluation. The risk-benefit ratio may be less favorable in this group due to the potential for underlying coronary artery disease and the use of medications like beta-blockers or ACE inhibitors.
No dosage adjustment is required. The metabolic breakdown of the proteins in the extract does not rely on renal function. However, overall health status should be stable.
No dosage adjustment is required. The liver is not the primary site of action or clearance for these allergenic proteins.
> Important: Special populations, particularly pregnant women and the elderly, require individualized medical assessment and frequent monitoring during allergy treatment.
Artemisia Vulgaris Pollen extract acts as an immunomodulator. Its primary molecular targets are the IgE receptors on mast cells and basophils (for diagnosis) and the T-cell receptor/cytokine signaling pathways (for therapy). The major allergen, Art v 1, is a defensin-like protein that is highly immunogenic. During immunotherapy, the repeated exposure to these proteins induces a shift from a Th2 (allergic) response to a Th1/T-reg (tolerant) response, increasing the production of IL-10 and IgG4 antibodies.
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous/Local) |
| Protein Binding | Primarily to IgE and IgG4 |
| Half-life | Minutes to hours (as proteins) |
| Tmax | 30-60 minutes (systemic absorption) |
| Metabolism | Proteolysis (Tissue/Blood) |
| Excretion | Renal (as peptide fragments) |
Artemisia Vulgaris Pollen is classified as a Non-Standardized Pollen Allergenic Extract. It is grouped with other weed pollens like Ragweed and Pigweed. Unlike "Standardized" extracts (like Grass or Cat), its potency is not measured by a federally mandated bioassay, but rather by the manufacturer's internal standards (PNU or w/v).
Common questions about Artemisia Vulgaris Pollen
Artemisia Vulgaris Pollen, or Mugwort pollen, is primarily used for the diagnosis and treatment of seasonal allergies. In a clinical setting, it is used in skin prick tests to determine if a patient is allergic to mugwort weeds. It is also used in allergen immunotherapy, commonly known as allergy shots, to help the body build up a tolerance to the pollen over time. This treatment is intended for patients who suffer from allergic rhinitis (hay fever) or allergic asthma that is triggered by mugwort during the late summer and fall. By receiving regular injections of the extract, patients can experience a significant reduction in their allergy symptoms and their need for daily medications.
The most common side effects are localized reactions at the site of the injection or skin test. These typically include redness, itching, and a raised bump or swelling (wheal) that looks like a mosquito bite. These reactions usually appear within minutes and resolve on their own within a few hours. Some patients may also experience a 'delayed' local reaction, where the swelling appears several hours later. While these local effects are common and generally not dangerous, they should be reported to your doctor, as a very large local reaction may require a dose adjustment for your next injection.
It is strongly recommended that you avoid alcohol consumption on the days you receive an Artemisia Vulgaris Pollen injection. Alcohol can cause your blood vessels to dilate (expand), which may speed up the absorption of the allergen into your bloodstream. This increased absorption rate can raise the risk of a systemic allergic reaction or make a reaction more severe if it occurs. Furthermore, alcohol can sometimes make it harder for you to recognize the early warning signs of an allergy flare-up. Always wait at least several hours after your injection and ensure you feel completely well before consuming alcohol.
Artemisia Vulgaris Pollen is generally not started during pregnancy because of the risk of anaphylaxis, which can be dangerous for both the mother and the developing baby. If a woman is already on a stable maintenance dose of allergy shots and becomes pregnant, many doctors will allow her to continue the treatment since the risk of a reaction is much lower at that stage. However, the dose is usually not increased during pregnancy. Decisions regarding immunotherapy during pregnancy are made on a case-by-case basis by an allergist. If you are planning to become pregnant or find out you are pregnant while on this treatment, you should notify your doctor immediately.
Immunotherapy with Artemisia Vulgaris Pollen is a long-term process and does not provide immediate relief like an antihistamine would. Most patients begin to notice an improvement in their allergy symptoms toward the end of the 'build-up' phase, which usually takes 3 to 6 months. Significant clinical benefits are typically seen after the first full mugwort pollen season once the maintenance dose has been reached. For the best and most lasting results, the treatment is usually continued for 3 to 5 years. This duration allows the immune system to fully adjust and maintain its tolerance even after the injections are stopped.
Yes, you can stop taking the injections suddenly without experiencing a withdrawal syndrome like you might with some other medications. However, stopping the treatment before the recommended 3-to-5-year course is finished will likely result in your allergy symptoms returning over time. Immunotherapy works by gradually retraining your immune system, and this process requires consistency. If you need to stop treatment due to side effects, financial reasons, or a move, you should discuss this with your allergist. They can advise you on whether your immune system has had enough exposure to provide any lasting benefit.
If you miss a scheduled injection, you should contact your allergist's office as soon as possible to reschedule. Do not try to make up for the missed dose by taking a higher dose later. The safety of immunotherapy depends on the timing of the injections; if too much time passes between doses, your body may lose some of its tolerance, making the next injection riskier. Depending on how long it has been since your last shot, your doctor may need to repeat your previous dose or even reduce the dose slightly to ensure you do not have a reaction when you resume treatment.
There is no clinical evidence to suggest that Artemisia Vulgaris Pollen extracts cause weight gain. The extract consists of proteins and glycoproteins that work locally and systemically on the immune system but do not affect metabolism, appetite, or fat storage. If you experience weight gain while undergoing immunotherapy, it is likely due to other factors, such as lifestyle changes or other medications you may be taking (like oral steroids for asthma). Always discuss any unexpected physical changes with your healthcare provider to determine the underlying cause.
Artemisia Vulgaris Pollen can be taken alongside most common allergy medications like antihistamines and nasal sprays, but it has serious interactions with certain heart and blood pressure drugs. Specifically, beta-blockers can make it very difficult to treat a severe allergic reaction if one occurs. Other drugs like ACE inhibitors and certain antidepressants (MAOIs) can also increase the risk or severity of a reaction. It is vital that you provide your allergist with a complete list of all medications you are taking, including over-the-counter drugs and supplements, to ensure your safety during treatment.
Allergenic extracts like Artemisia Vulgaris Pollen are biological products rather than simple chemical drugs, so the term 'generic' does not apply in the traditional sense. However, multiple different manufacturers produce mugwort pollen extracts. While these products are similar, they are not considered interchangeable because their concentrations and potencies can vary. If your doctor switches you from one manufacturer's extract to another, they will usually restart the build-up process or significantly reduce the dose to ensure your safety, as your body may react differently to the new preparation.